Cancer treatment

Cancer treatment encompasses a wide array of therapeutic strategies aimed at controlling or eliminating cancerous cells within the body. These strategies include chemotherapy, radiation therapy, immunotherapy, targeted therapy, and surgical interventions. Each treatment modality targets different aspects of cancer cell biology, such as cell division, DNA replication, or immune evasion. Research in cancer treatment focuses on improving the efficacy, specificity, and safety of these therapies to enhance patient outcomes and reduce side effects. At CymitQuimica, we provide a comprehensive range of compounds and reagents to support your research in developing innovative and effective cancer treatments.

20
- 50
- 100
- 200

products per page. 985 products on this category.

Product data	Purity	Price range	Estimated delivery
Leuprorelin (Leuprolide) Impurity 2 Tritrifluoroacetate REF: 4Z-PL-4117CAS: 1642799-35-6	- - -	To inquire	Mon 16 Dec 24
Goserelin EP Impurity J Ditrifluoroacetate REF: 4Z-PG-1514	- - -	To inquire	Mon 16 Dec 24
Leuprolide (1-3) REF: TM-T32684CAS: 35925-21-4	- - -	To inquire	Mon 16 Dec 24
Leuprorelin (Leuprolide) EP Impurity C REF: 4Z-PL-415CAS: 54785-87-4	- - -	To inquire	Mon 16 Dec 24
Tamoxifen EP Impurity D HCl (E-Isomer) REF: 4Z-T-0127CAS: 15917-51-8	- - -	To inquire	Mon 16 Dec 24
Abiraterone Impurity 49 (Pregnenolone-16-ene Acetate) REF: 4Z-A-8210CAS: 979-02-2	- - -	To inquire	Mon 16 Dec 24
Enzalutamide Impurity 20 REF: 4Z-E-068033CAS: 1242137-19-4	- - -	To inquire	Mon 16 Dec 24
Carfilzomib Impurity 30 REF: 4Z-C-121033	- - -	To inquire	Mon 16 Dec 24
Nintedanib N1-Oxide (Intedanib N1-Oxide) REF: 4Z-N-066024	- - -	To inquire	Mon 16 Dec 24
Enzalutamide Impurity 63 REF: 4Z-E-068079	- - -	To inquire	Mon 16 Dec 24
Enzalutamide Impurity 62 REF: 4Z-E-068007CAS: 749927-69-3	- - -	To inquire	Mon 16 Dec 24
Lenvatinib Impurity 13 REF: 4Z-L-124017CAS: 417724-81-3	- - -	To inquire	Mon 16 Dec 24
Tamoxifen Citrate REF: 4Z-T-015CAS: 54965-24-1	- - -	To inquire	Mon 16 Dec 24
Abiraterone Impurity 20 REF: 4Z-A-8230CAS: 2484719-17-5	- - -	To inquire	Mon 16 Dec 24
Carfilzomib Impurity 3 REF: 4Z-C-121006	- - -	To inquire	Mon 16 Dec 24
Gimeracil Impurity 4 (Cyanuric Acid) REF: 4Z-G-047004CAS: 108-80-5	- - -	To inquire	Mon 16 Dec 24
Abiraterone Impurity 10 REF: 4Z-A-8247CAS: 165334-71-4	- - -	To inquire	Mon 16 Dec 24
N-Nitrosopalbociclib REF: 86-MM3729.01-0025	- - -	2,088.00 €	Wed 18 Dec 24
Olaparib REF: 86-MM3926.00-0250CAS: 763113-22-0	- - -	2,193.00 €	Wed 18 Dec 24
4-[[4-Fluoro-3-(1-piperazinylcarbonyl)phenyl]methyl]-1(2H)-phthalazinone REF: 86-MM3926.05-0025CAS: 763111-47-3	- - -	To inquire	Wed 18 Dec 24

10mg		To inquire
25mg		To inquire
50mg		To inquire
100mg		To inquire

10mg		To inquire
25mg		To inquire
50mg		To inquire
100mg		To inquire

100mg		To inquire
500mg		To inquire

10mg		To inquire
25mg		To inquire
50mg		To inquire
100mg		To inquire

Cancer treatment

Leuprorelin (Leuprolide) Impurity 2 Tritrifluoroacetate

Ref: 4Z-PL-4117

Goserelin EP Impurity J Ditrifluoroacetate

Ref: 4Z-PG-1514

Leuprolide (1-3)

Ref: TM-T32684

Leuprorelin (Leuprolide) EP Impurity C

Ref: 4Z-PL-415

Tamoxifen EP Impurity D HCl (E-Isomer)

Ref: 4Z-T-0127

Abiraterone Impurity 49 (Pregnenolone-16-ene Acetate)

Ref: 4Z-A-8210

Enzalutamide Impurity 20

Ref: 4Z-E-068033

Carfilzomib Impurity 30

Ref: 4Z-C-121033

Nintedanib N1-Oxide (Intedanib N1-Oxide)

Ref: 4Z-N-066024

Enzalutamide Impurity 63

Ref: 4Z-E-068079

Enzalutamide Impurity 62

Ref: 4Z-E-068007

Lenvatinib Impurity 13

Ref: 4Z-L-124017

Tamoxifen Citrate

Ref: 4Z-T-015

Abiraterone Impurity 20

Ref: 4Z-A-8230

Carfilzomib Impurity 3

Ref: 4Z-C-121006

Gimeracil Impurity 4 (Cyanuric Acid)

Ref: 4Z-G-047004

Abiraterone Impurity 10

Ref: 4Z-A-8247

N-Nitrosopalbociclib

Ref: 86-MM3729.01-0025

Olaparib

Ref: 86-MM3926.00-0250

4-[[4-Fluoro-3-(1-piperazinylcarbonyl)phenyl]methyl]-1(2H)-phthalazinone

Ref: 86-MM3926.05-0025